# An Open, Randomized, Multicentre, Phase II Pilot Study

> **NCT00293085** · PHASE2 · COMPLETED · sponsor: **Central European Cooperative Oncology Group** · enrollment: 37 (actual)

## Conditions studied

- Non-Small Cell Lung Cancer

## Interventions

- **DRUG:** Docetaxel
- **DRUG:** Docetaxel

## Key facts

- **NCT ID:** NCT00293085
- **Lead sponsor:** Central European Cooperative Oncology Group
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-12
- **Primary completion:** —
- **Final completion:** 2003-09
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2011-06-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00293085

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00293085, "An Open, Randomized, Multicentre, Phase II Pilot Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00293085. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*